Brief: Sensei Biotherapeutics Reports First Quarter 2022 Financial Results And Recent Business Highlights
10/05/2022 12:31
May 10 (Reuters) - Sensei Biotherapeutics Inc SNSE.O :
* SENSEI BIOTHERAPEUTICS REPORTS FIRST QUARTER 2022
FINANCIAL
RESULTS AND RECENT BUSINESS HIGHLIGHTS
* SENSEI BIOTHERAPEUTICS INC - EXPECTS CURRENT CASH BALANCE
TO
FUND OPERATIONS INTO Q1 OF 2025
* SENSEI BIOTHERAPEUTICS INC - QTRLY NET LOSS PER SHARE
$0.40
Source text for Eikon: ID:nGNX2JK0Nn
Further company coverage: SNSE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Faeth Therapeutics
See all newsU.S. STOCKS ON THE MOVE - Nvidia, Gold miners, Nike
U.S. STOCKS ON THE MOVE - Sunrun, JetBlue Airways, Dell Technologies
Faeth Therapeutics rises after FDA grants fast-track status for cancer drug
Brief: Faeth Therapeutics Announces FDA Grant Of Fast Track Designation For Piktor Plus Paclitaxel In Biomarker-Selected Advanced Endometrial Cancer
Brief: Faeth Therapeutics Strengthens Executive Team With Senior Leadership Appointments